Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
(S)-5-tert-Butoxy-4-(3-((s)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic Acid is used as a reactant in the synthesis of a DUPVIP(LA)paclitaxel conjugate for antigen targeted therapy of prostate cancer.